SearchCatalogResearchCommunityTools
Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Recovery / Skin Regeneration StackEvidence Grade: B (Both Compounds)

BPC-157 + GHK-Cu Stack Protocol Guide

The BPC-157 + GHK-Cu stack combines two of the most researched regenerative peptides for comprehensive tissue repair and skin rejuvenation. BPC-157 promotes angiogenesis, upregulates growth factors (VEGF, EGF, FGF), and accelerates wound healing from the inside out. GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex) is a naturally occurring tripeptide that stimulates collagen synthesis, glycosaminoglycan production, and tissue remodeling while providing potent antioxidant protection. Together, BPC-157 drives new blood vessel formation while GHK-Cu rebuilds the extracellular matrix and enhances skin quality.

Protocol Overview

Compounds
BPC-157 + GHK-Cu
Category
Tissue Repair / Skin Regeneration
Mechanism
BPC-157: angiogenesis, growth factor upregulation, nitric oxide modulation. GHK-Cu: collagen/elastin synthesis, metalloproteinase regulation, stem cell attraction
Half-Life
BPC-157: ~4 hrs | GHK-Cu: ~2-4 hrs
Route
BPC-157: SubQ | GHK-Cu: SubQ or topical
Frequency
BPC-157: 1x daily | GHK-Cu: 1-2x daily
Cycle Length
6-12 weeks

Synergy & Mechanism

BPC-157 Mechanism

BPC-157 is a pentadecapeptide derived from human gastric juice that promotes tissue healing through angiogenesis (new blood vessel formation), upregulation of VEGF, EGF, and FGF growth factors, and nitric oxide modulation. It creates the vascular infrastructure needed to deliver nutrients and building materials to damaged tissue.

GHK-Cu Synergy

GHK-Cu is a copper-binding tripeptide that naturally declines with age. It stimulates collagen I, III, and V synthesis, elastin production, and glycosaminoglycan formation. While BPC-157 builds the vascular highway, GHK-Cu provides the structural materials for tissue remodeling. GHK-Cu also attracts stem cells and reduces oxidative damage at repair sites.

Combined Dosing Protocol

ProtocolCompound 1Compound 2TimingDuration
StandardBPC-157 250mcg/day SubQGHK-Cu 200mcg/day SubQAM6-8 weeks
EnhancedBPC-157 500mcg/day SubQGHK-Cu 400mcg/day SubQAM + PM split8-12 weeks
Topical ComboBPC-157 250mcg/day SubQGHK-Cu cream 2x/day topicalAM + PM8 weeks

Reconstitution & Preparation

BPC-157 Preparation

  • BPC-157 vial: typically 5mg lyophilized
  • Reconstitute with 2mL BAC water = 2,500mcg/mL
  • 250mcg dose = 10 units on insulin syringe
  • Refrigerate, use within 30 days

GHK-Cu Preparation

  • GHK-Cu vial: typically 50mg lyophilized
  • Reconstitute with 2mL BAC water = 25mg/mL
  • 200mcg dose = 0.8 units on insulin syringe
  • Also available as topical cream (0.1-1%)

Stacking Schedule (AM/PM Timing)

AM Protocol

  • Morning: BPC-157 250mcg SubQ near target area
  • Morning: GHK-Cu 200mcg SubQ (same area or facial)
  • Inject sequentially at slightly different sites
  • Do not mix in same syringe

PM Protocol (Enhanced)

  • Evening: GHK-Cu topical cream to target skin
  • Or second SubQ dose of GHK-Cu 200mcg
  • BPC-157 can be split AM/PM for aggressive protocols
  • Consistent daily dosing is key

Expected Timeline

Week 1-2
BPC-157 initiates angiogenesis. GHK-Cu begins collagen stimulation. Early skin texture improvement and minor wound healing acceleration.
Week 3-4
Synergistic healing apparent. New blood vessels deliver nutrients for GHK-Cu matrix remodeling. Skin quality visibly improves.
Week 5-8
Peak regenerative effects. Significant improvement in skin firmness, elasticity, wound healing. Scar tissue remodeling begins.
Week 9-12
Continued tissue remodeling. Collagen maturation. Long-term improvements in skin appearance and tissue integrity.

Side Effects & Monitoring

Common Side Effects

  • Injection site redness (mild, transient)
  • Mild dizziness (uncommon)
  • Skin flushing at GHK-Cu injection site
  • Metallic taste (GHK-Cu, rare)

Both compounds have excellent safety profiles with minimal adverse effects at standard doses.

Precautions

  • GHK-Cu contains copper - avoid in Wilson's disease
  • May promote angiogenesis in tumors (theoretical)
  • Avoid if active cancer or cancer history
  • Limited human clinical trial data for injectable GHK-Cu

Blood Work Recommendations

PanelMarkersTiming
InflammatoryCRP, ESRBaseline, Week 4, Week 8
BasicCBC, CMPBaseline, Week 6
CopperSerum copper, ceruloplasminBaseline, Week 6 (if concerned)

Monitor inflammatory markers to track healing. Check copper levels if using high-dose GHK-Cu for extended periods.

Related Protocols & Tools

★ OFFICIAL SPONSOR
BioRoot AI
Free Functional Assessment
AI-powered root cause analysis & care plan
Start Free
Paid partnership ยท Learn more
Share & Save
๐• Share on Twitter ๐Ÿ“ฑ Share on Reddit ๐Ÿ’ฌ WhatsApp โœ‰๏ธ Email ๐Ÿ”— Copy Link ๐Ÿ–จ๏ธ Print / Save PDF โ˜… Save to Favorites